Combo Thrombolytic Approach Fails to Reduce ICH in Stroke
The DUMAS study showed no benefit on the primary outcome of all ICH with low-dose alteplase followed by mutant pro-urokinase; but there were promising signs of a potential reduced bleeding risk.
Medscape Medical News
source https://www.medscape.com/viewarticle/983412?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/983412?src=rss
Comments
Post a Comment